Home TMU Sitemap FAQ Links
正體中文
Home Ongoing Clinical Trials
Ongoing Clinical Trials

Institution
Principal Investigator
Protocol Title
Keyword
TMU-JIRB No. Protocol Title Institution / Principal Investigator dictionary.testing.TypeOfStudy dictionary.testing.PhasesOfClinicalTrialsForDrugs
N202607025 A preliminary bioequivalence study to compare two lurasidone HCl tablets in healthy subjects under fed state. Bioavailability / Bioequivalence (BA/BE) NA
N202607026 An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan New Drug PMS(Post Marketing Surveillance)
N202607051 An Exploratory Phase 2 Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Investigate the Safety, Tolerability, and Efficacy of TML-6 in Early Alzheimer’s Disease New Drug Phase Ⅱ
N202607060 A phase 3, randomized, parallel, multicenter, double-blind, placebo-controlled study to investigate efficacy and safety of KP-001 in patients aged ≥2 years with common venous malformations, common lymphatic malformations, or KTS/CLOVES syndrome New Drug Phase Ⅲ
N202607069 A Phase 3, Randomized, Multicenter, Double-blind Study to Assess Stroke and Systemic Embolism Prevention with REGN7508, a Monoclonal Antibody Against Factor XI, Versus Apixaban in Participants with Atrial Fibrillation (ROXI-EVEREST) New Drug Phase Ⅲ
N202607070 A Phase 1 Clinical Trial of ACE723, A Dual-Payload Antibody Drug Conjugate Targeting Glypican-3 (GPC-3), in Patients with Unresectable or Metastatic Hepatocellular Carcinoma (HCC) Who Have Failed or Progressed on Standard Immune Checkpoint Inhibitor-Containing Systemic Therapies New Drug Phase Ⅰ
N202607082 The use of Osteo-Inductive-Factor/β-Tri-Calcium Phosphate (OIF/β-TCP) for the Alveolar Ridge Preservation. New Medical Device NA
N202607098 A Randomized, Open-label, Phase 3 Trial of Petosemtamab in Combination With mFOLFOX6 or FOLFIRI Versus Cetuximab in Combination With mFOLFOX6 or FOLFIRI as First-line Treatment for Participants With RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer New Drug Phase Ⅲ
N202607099 An Open-Label, Single Arm, Phase 2a Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Mild-to-Moderate Alopecia Areata New Drug Phase Ⅱ
N202607102 Development and Validation of Transcutaneous Vagus Nerve Stimulation Therapeutics Medical Device for Symptoms of Anxiety among Psychiatric Outpatients New Medical Device NA
1 2 43 44 45 46 47 48 49 50 51 52 / 52

TOP